Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Intercell, a developer of vaccines for the prevention and treatment of infectious diseases, has appointed Reinhard Kandera as its new CFO. The prior CFO, Werner Lanthaler, has left the company to join Evotec as CEO.
Subscribe to our email newsletter
In his new role, Mr Kandera will be responsible for the global finance function and investor relations of Intercell. Mr Kandera is currently CFO of Intercell’s US subsidiary formerly Iomai, which was acquired in 2008.
Mr Kandera joined Intercell in 2001 and has held various positions within finance including global head of investor relations and head of finance and controlling. Before joining Intercell, Mr Kandera worked for Deutsche Bank. Mr Kandera holds doctorate degrees in both law and finance.
Gerd Zettlmeissl, CEO of Intercell, said: “It has been a great experience for me and the management board and all employees of Intercell to build the company together with Werner. We understand and respect his decision and we would like to express our deep gratitude for his outstanding performance.
“We are very happy that Reinhard Kandera will now take over the role of the CFO. His experience and knowledge of all company processes make him highly qualified for the next growth phase of Intercell.”